Please assess the completion status of the following clinical trial:

Trial Title: Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. A previously placed prophylactic cerclage defined as any cerclage done \< 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation \< 3 cm~2. Spontaneous rupture of membranes 22-32 weeks~3. Singleton or twin gestation~4. Shirodkar or McDonald cerclage in place \> 1 week~Exclusion Criteria:~1. Active labor (\> 8 uterine contractions \[UCs\] per hour)~2. Chorioamnionitis as defined by temperature \> 38 plus fetal tachycardia or uterine tenderness~3. Placenta previa or undiagnosed vaginal bleeding~4. Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)~5. Mature pulmonary studies~6. Positive gram stain, culture, white blood cells (WBC) \> 30, or glucose \< 14 on amniocentesis~7. Major fetal anomaly~8. Presentation \> 48 hours after rupture of membranes~9. abdominal cerclage~10. Cerclage done for symptomatic cervical dilation (cervix dilated \> 3 cm)~11. Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 Retention of Cerclage (Type: ACTIVE_COMPARATOR): Group one = Subject whose Cerclage is retained after randomization.
- 2 - Removal of Cerclage (Type: ACTIVE_COMPARATOR): Group 2 = Subjects who will have cerclage removed after randomization

Based on this trial design, predict the completion outcome and termination type (if applicable).